Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations
- PMID: 8895741
Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations
Abstract
The progression of prostatic intraepithelial neoplasia (PIN) to invasive prostate carcinoma has been analyzed in the C3(1)/T(AG) transgenic mouse model and appears very similar to the process proposed to occur in humans. PIN lesions in these transgenic mice histologically resemble those found in human PIN. Low-grade PIN was observed in the ventral and dorsolateral lobes at 2 months of age, whereas high-grade PIN was found in both lobes by 5 months of age. A progressive increase in the number of PIN lesions was observed with age. Prostate carcinomas, which appeared to arise from PIN lesions, were found by 7 months of age in the ventral lobe and 11 months of age in the dorsolateral lobe. Expression of T(AG) mRNA and protein in these lesions correlated with the development of PIN and carcinomas, as did the overexpression of p53 protein. Apoptosis levels were quite low in normal epithelial cells, moderate in low-grade PIN, and high in high-grade PIN and carcinomas. Levels of expression of proliferating cell nuclear antigen correlated with the degree of severity of the prostate lesions. Eighteen % of PIN lesions were found to already harbor Ha-ras mutations, whereas 33% of carcinomas showed various mutations in Ha-ras, Ki-ras, and/or p53. Mutations in Ha-ras may, therefore, be an early event in a significant portion of PIN lesions. Because high-grade PIN showed many characteristics similar to those observed in carcinomas and high-grade PIN was often found contiguous to carcinomas, we conclude that high-grade PIN is a precursor lesion of prostate carcinoma in this transgenic model. These transgenic mice will be useful to study mechanisms responsible for the progression of invasive carcinomas from PIN precursor lesions, as may occur during the development of prostate cancer in humans.
Similar articles
-
A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.Cancer Res. 2001 Mar 1;61(5):2239-49. Cancer Res. 2001. PMID: 11280793
-
Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.Clin Cancer Res. 2004 Nov 15;10(22):7727-37. doi: 10.1158/1078-0432.CCR-04-0732. Clin Cancer Res. 2004. PMID: 15570007
-
2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.Cancer Res. 2001 Oct 15;61(20):7449-55. Cancer Res. 2001. PMID: 11606379
-
Genetic alterations in the development of mammary and prostate cancer in the C3(1)/Tag transgenic mouse model.Int J Oncol. 1998 Feb;12(2):449-53. Int J Oncol. 1998. PMID: 9458374 Review.
-
The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues.J Urol. 1997 Jul;158(1):12-22. doi: 10.1097/00005392-199707000-00004. J Urol. 1997. PMID: 9186314 Review.
Cited by
-
Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia.Mol Cell Biol. 2002 Mar;22(5):1495-503. doi: 10.1128/MCB.22.5.1495-1503.2002. Mol Cell Biol. 2002. PMID: 11839815 Free PMC article.
-
Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.PLoS One. 2016 May 12;11(5):e0155262. doi: 10.1371/journal.pone.0155262. eCollection 2016. PLoS One. 2016. PMID: 27171183 Free PMC article.
-
Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice.Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3455-60. doi: 10.1073/pnas.97.7.3455. Proc Natl Acad Sci U S A. 2000. PMID: 10737798 Free PMC article.
-
A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15382-7. doi: 10.1073/pnas.95.26.15382. Proc Natl Acad Sci U S A. 1998. PMID: 9860977 Free PMC article.
-
p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of laser capture microdissected specimens from non-transition and transition zones.Jpn J Cancer Res. 2000 Sep;91(9):941-7. doi: 10.1111/j.1349-7006.2000.tb01038.x. Jpn J Cancer Res. 2000. PMID: 11011123 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous